Dr Siddhartha Kadia has experience in executive management and public company governance in global businesses, predominantly in the Life Sciences and TIC (Testing, Inspection and Certification) industries. He has experience in global markets with an emphasis on North America, Asia and Europe. His experience includes CEO-level executive leadership, corporate strategy, M&A, laboratory operations, global marketing and ebusiness. Dr Kadia was a former president and chief executive of EAG Laboratories in San Diego which was acquired by Eurofin Scientific in 2017, and he continued to serve as the chief executive of EAG laboratories until December 2018. Prior to EAG, he held executive roles with Life Technologies Corporation including as president of life sciences; president of Greater China region; president of Japan; and chief marketing officer. Dr Kadia also worked with McKinsey and company as a management consultant. He served on the boards of Newport Corporation and Volcano Corporation. He was awarded the David Israel Macht Award for his research.
